Boston Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-70,922
Closed -$604K 766
2022
Q3
$604K Sell
70,922
-409,706
-85% -$4.03M ﹤0.01% 575
2022
Q2
$5.03M Buy
480,628
+28,874
+6% +$317K 0.01% 383
2022
Q1
$4.92M Sell
451,754
-34,931
-7% -$460K 0.01% 396
2021
Q4
$6.58M Sell
486,685
-100,941
-17% -$1.35M 0.01% 378
2021
Q3
$7.96M Sell
587,626
-7,316
-1% -$104K 0.01% 373
2021
Q2
$8.5M Buy
594,942
+12,880
+2% +$186K 0.01% 370
2021
Q1
$8.13M Sell
582,062
-4,899,078
-89% -$79.8M 0.01% 369
2020
Q4
$103M Buy
+5,481,140
New +$89.4M 0.16% 186
2018
Q3
Sell
-118,111
Closed -$4.27M 786
2018
Q2
$4.27M Buy
118,111
+17,161
+17% +$673K 0.01% 489
2018
Q1
$4.16M Sell
100,950
-41,519
-29% -$1.77M 0.01% 514
2017
Q4
$6.03M Buy
142,469
+12,439
+10% +$475K 0.01% 460
2017
Q3
$4.08M Sell
130,030
-12,638
-9% -$429K 0.01% 544
2017
Q2
$5.54M Sell
142,668
-23,056
-14% -$885K 0.01% 461
2017
Q1
$6.46M Buy
165,724
+33,862
+26% +$1.37M 0.01% 454
2016
Q4
$5.03M Hold
131,862
0.01% 501
2016
Q3
$5.03M Buy
131,862
+79,577
+152% +$3.54M 0.01% 493
2016
Q2
$2.26M Buy
52,285
+754
+1% +$33.4K ﹤0.01% 631
2016
Q1
$2.39M Buy
+51,531
New +$2.49M ﹤0.01% 588

Other funds holding VTRS

Boston Partners's VTRS Position: Q4 2022 in Review

Boston Partners sold out of Viatris (VTRS) in Q4 2022, closing a stake of 70,922 shares — an estimated $604K sold.

Boston Partners first reported a position in VTRS in Q1 2016 and held it in 18 quarters. The position peaked at $103M in Q4 2020. 1,015 funds tracked by Wall St. Rank hold VTRS as of Q4 2022.

  • Boston Partners reported no remaining Viatris position as of Q4 2022 after selling out during the quarter.
  • Boston Partners sold 70,922 Viatris shares in Q4 2022, an estimated $604K.
  • Boston Partners first reported a position in Viatris in Q1 2016 and held it in 18 quarters.
  • Boston Partners's Viatris position peaked at $103M in Q4 2020.
  • 1,015 funds tracked by Wall St. Rank held Viatris as of Q4 2022.

Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.